Reuters - Video

Edition: US | UK | IN | CN | JP

video Video

Bernanke steps into the spotlight
Bernanke steps into the spotlight - 02:13
The official royal wedding guest list revealed
The official royal wedding guest list revealed - 01:23
Shuttle astronauts arrive at Cape Canaveral
Shuttle astronauts arrive at Cape Canaveral - 01:18
Waiting for Bernanke
Waiting for Bernanke - 01:51
Hospital staff flee border fighting
Hospital staff flee border fighting - 01:10
Thousands at Sai Baba funeral
Thousands at Sai Baba funeral - 01:03
Al Qaeda releases hostage messages
Al Qaeda releases hostage messages - 01:43
Obama calls birth controversy \
Obama calls birth controversy "distracting" - 05:29
Three blasts hit Kirkuk
Three blasts hit Kirkuk - 01:25
Protests intensify in Yemen
Protests intensify in Yemen - 01:24
Border clashes displace thousands
Border clashes displace thousands - 01:50
S&P Credit Rating Warning Helpful - Lister
S&P Credit Rating Warning Helpful - Lister - 00:53

Valeant ditches Philidor

Friday, October 30, 2015 - 01:12

The Canadian drug maker's move comes a day after three big drug benefit managers severed their ties with the embattled mail order pharmacy. Fred Katayama reports.

▲ Hide Transcript

▶ View Transcript

More fallout for Valeant. Valeant Pharmaceuticals is cutting ties with the mail order pharmacy, Philidor Rx, the subject of criticism by short seller Citron Research. The embattled Canadian drug maker said it has "lost confidence" in Philidor's ability to operate in an acceptable manner. Valeant had a board committee look into Citron's allegations that it had used Philidor to create "phantom sales" of its drugs. Philidor makes up nearly 7 percent of Valeant's revenue. Valeant says Philidor will shut down operations as soon as possible. Valeant's move comes one day after pharmacy benefit managers CVS Health, Express Scripts, and OptumRx said they will stop using Philidor. The acquisition-hungry stock market darling that attracted star activist investors such as Bill Ackman and Jeffrey Ubben has become a dog. Valeant's latest nightmare began nine days ago when short seller Citron accused the company of fraud. Its stock has fallen 24 percent since then, and it fell further in early trading Friday. It has lost more than half of its value since early August. Also pressuring the stock: attacks by Democratic politicians over their skyrocketing prices for some key drugs.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Close

Valeant ditches Philidor

Friday, October 30, 2015 - 01:12

Featured Videos

London's female wrestling scene boosted by Netflix show 'Glow'

London's female wrestling scene boosted by Netflix show 'Glow'

There has been more interest in female wrestling and a clearer sense of what it involves since hit Netlfix show 'Glow' came out
Chimpanzees can understand rock, paper, scissors

Chimpanzees can understand rock, paper, scissors

Chimpanzees can understand rock, paper, scissors, Japanese primatologists show
Bladerunners - UK lawnmowers in 12-hour endurance race

Bladerunners - UK lawnmowers in 12-hour endurance race

Drivers donned their suits and climbed into their cockpits at the weekend for a 12-hour endurance race with a difference: they weren't driving rallying cars, but lawnmowers
The highs and lows of Macron's first 100 days

The highs and lows of Macron's first 100 days

French President Emmanuel Macron heads into the summer break faced with falling popularity ratings after tough debates in parliament over labour reform and a public ethics law, a standoff with the military and cuts to housing assistance
The vending machine helping fight against HIV

The vending machine helping fight against HIV

An innovative vending machine for HIV tests being piloted in Britain aims to help in the fight to end the epidemic